SPES Low-energy Beamline Status and Development of ISOLPHARM Radionuclide Implantation Station (IRIS)

SPES (Selective Production of Exotic Species) is a second-generation ISOL (Isotope Separation On-Line) facility to produce Radioactive Ion Beams (RIBs), under completion stage at the Laboratori Nazionali di Legnaro of the Istituto Nazionale di Fisica Nucleare (LNL-INFN), Padua, Italy. ISOLPHARM (ISOL technique for radioPHARMaceuticals), within the SPES medical production program, is a research activity dedicated to developing innovative radiopharmaceuticals exploiting the high purity radionuclides produced using the ISOL technique. Within this scope, ISOLPHARM Radionuclide Implantation Station (IRIS) is designed to be coupled with the SPES low-energy beamline to handle the collection of medical radionuclides. In this paper, a detailed description on the design of collection substrates and IRIS components is reported. The on-site commissioning comprising the reliability tests and offline calibration tests of the detection system is also presented. IRIS is expected to begin operation with initial experiments at SPES facility in the near future.